This inventor holds 1 USPTO granted patent. Top assignee: Cell Pathways. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: I Bernard Weinstein: Innovator in Neoplasia Treatment
Introduction
I Bernard Weinstein is a notable inventor based in Englewood, NJ (US). He has made significant contributions to the field of medical research, particularly in the treatment of neoplasia. His innovative approach has led to the development of a method that holds promise for improving therapeutic strategies against cancer.
Latest Patents
Weinstein holds a patent for a "Method for screening compounds for the treatment of neoplasia." This invention provides a method to identify compounds potentially useful for the treatment and prevention of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with its ability to elevate JNK kinase activity. Growth inhibitory and apoptosis-inducing effects on cultured tumor cells are also assessed. Compounds that exhibit phosphodiesterase inhibition, an ability to elevate JNK kinase activity, growth inhibition, and apoptosis induction are desirable for the treatment of neoplasia. He has 1 patent to his name.
Career Highlights
Weinstein is associated with Cell Pathways, a company dedicated to advancing cancer treatment through innovative research. His work has been instrumental in developing new methodologies that enhance the understanding of neoplasia and its treatment.
Collaborations
Some of his notable coworkers include W Joseph Thompson and Jae-Won Soh. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.
Conclusion
I Bernard Weinstein's contributions to the treatment of neoplasia through innovative methods highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in cancer research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
